Average Co-Inventor Count = 4.48
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (28 from 290 patents)
2. Abbvie Inc. (3 from 822 patents)
3. Dr. Reddy's Laboratories, Incorporated (2 from 187 patents)
4. Enata Pharmacueticals, Inc. (1 from 1 patent)
5. Abbvie Bahamas Limited (6 patents)
6. Abbvie Ireland Unlimited Company (0 patent)
32 patents:
1. 10131655 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
2. 9493506 - Macrocyclic hepatitis C serine protease inhibitors
3. 9487510 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
4. 9309279 - Macrocyclic hepatitis C serine protease inhibitors
5. 9193740 - Bismacrocyclic compounds as hepatitis C virus inhibitors
6. 8962551 - Quinoxalinyl derivatives
7. 8951998 - Quinoxaline-containing compounds as hepatitis C virus inhibitors
8. 8940688 - Fluorinated tripeptide HCV serine protease inhibitors
9. 8936781 - Macrocyclic compounds as hepatitis C virus inhibitors
10. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
11. 8748374 - Macrocyclic hepatitis C serine protease inhibitors
12. 8501682 - Difluorinated tripeptides as HCV serine protease inhibitors
13. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors
14. 8377872 - Cyclic P3 tripeptide hepatitis C serine protease inhibitors
15. 8372802 - Fluorinated macrocyclic compounds as hepatitis C virus inhibitors